The table below shows Fulgent Genetics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$71.14M
$84.07M
$81.80M
$73.46M
$71.74M
$71.03M
Cost of revenue
$49.65M
$48.56M
$47.37M
$45.12M
$44.97M
$44.54M
Gross profit
$21.49M
$35.51M
$34.44M
$28.35M
$26.77M
$26.49M
R&D
$14.18M
$13.86M
$13.48M
$12.39M
$11.78M
$13.49M
FLGT annual revenue (10-K history)
Fulgent Genetics, Inc. reported annual revenue of $322.67M for fiscal year 2025. That is up 13.8% from $283.47M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $18.28M (FY 2016) to $322.67M. Figures come from the company's audited annual reports as filed with the SEC.